Skip to main content
Premium Trial:

Request an Annual Quote

Anil Singhal, Edward Tenthoff, Muzammil Mansuri

Premium

Anil Singhal has become chief drug development officer of Martinsried, Germany-based Xerion Pharmaceuticals. He will be based in the company’s Cambridge, Mass., office. Previously, he was vice president at Light Sciences and Pacific Pharmaceuticals, where he led oncology programs through preclinical and clinical stages of development.

 

Edward Tenthoff has joined U.S. Bancorp Piper Jaffray as a senior research analyst on the genomics sector. Tentoff comes to Piper Jaffray from Think Equity Partners, where he also covered genomics and biotechnology companies. Prior to this, Tenthoff covered biotechnology as a senior research analyst at the now-defunct firm Robertson Stephens.

 

Muzammil Mansuri, executive-in-residence at Flagship Ventures, has been appointed to the scientific advisory board of Achillion Pharmaceuticals. Mansuri is currently chairman of Beyond Genomics, and a director and executive chairman of Adaptive Therapeutics. He has previously served as executive vice president and chief operating officer at GPC Biotech. Between 1994 and 2000, Mansuri also held executive positions at Mitotix. Prior to this time, he worked at Bristol-Myers Squibb.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.